3528 results for «2025-12-19至2026-01-05+智光电气+异动分析»
3528 results
Visa and letter invitation
Start strong with PCR Fundamentals Course
GulfPCR-GIM - Relive the Best of the Course
Are you an EAPCI Member?
The Core Team shaping #PCRLV
Training Village Programme
Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines
03 Sep 2025
Alex Sticchi provides his take on the new ESC Valvular Guidelines presented at the ESC Congress 2025 in Madrid.
Author
EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...
2025 Andreas Grüntzig Ethica Award presented to Lars Wallentin and Stefan James on behalf of Swedish cardiovascular registry experts
20 May 2025
The Andreas Grüntzig Ethica Award is traditionally given to those who have contributed in an extraordinary way to the PCR mission, that of serving the needs of patients by sharing knowledge, experience and practice in cardiovascular interventional medicine.
The top ten impactful papers from 2025 on tricuspid intervention we almost missed
13 Jan 2026
Transcatheter interventions have rapidly reshaped the management of tricuspid valve disease, with landmark trials establishing feasibility and early clinical benefit.
Beyond these pivotal studies, a series of less visible but highly informative papers addressed mechanisms, complications, patient phenotypes, and unintended consequences of intervention.
This curated selection highlights ten impactful tricuspid...
Author
Spotlight on a selection of top Late-breaking Trials presented at PCR London Valves 2025
17 Nov 2025
View a snapshot of the results of these 4 trials in valvular and structural interventions presented in London during this year's Heart Team Course!
Meril presents successful LANDMARK RCT one-year results at prestigious EuroPCR 2025
21 May 2025
International Women's Day 2025: Raising awareness of aortic stenosis in women: - a silent killer
08 Mar 2025
It was a day in October last year when I had a meeting with patients’ group in UK. At the time, I needed to discuss with them why a registry on valvular heart disease and sex disparities is needed. The camaraderie was incredible and the discussion...
Author
Secure your grant for PCR London Valves
20 years of TEER: a journey at the crossroads of the human heart
20 Nov 2023 – From PCR London Valves 2023
In 2023, with 200,000 MitraClips performed, the session concluded by posing the question of how many M-TEERs would be conducted by 2026. While the answer remains a mystery until PCR LV 2026, explore the fascinating history of transcatheter edge-to-edge mitral valve repair in this session. Delve...
Integrating the newest valve guidelines into daily clinical reality
12 Sep 2025 – From PCR Rio Valves 2025
Integrate the 2025 EACTS valve guidelines into your clinical practice with a focus on valvular heart disease management tailored to Latin American realities. This session reviews the most relevant updates on aortic stenosis management and transcatheter approaches for mitral and tricuspid valves.
Watch the interview with Fabien...
Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies
21 May 2025 – From EuroPCR 2025
Explore how real-world data and evolving evidence are reshaping IV antithrombotic strategies in complex PCI. This EuroPCR 2025 session brings together urgent clinical cases—including STEMI patients in shock—and highlights key insights from the SMILE registry. Learn how transition protocols from cangrelor to oral P2Y12 inhibitors are...
Learning from lived experience and contemporary evidence: shaping the treatment of women with heart valve disease
17 Nov 2025 – From PCR London Valves 2025
This session provides an in-depth exploration of the lived experiences of women with valvular heart disease, emphasizing the unique challenges in detection, diagnosis, treatment, and follow-up. It integrates contemporary evidence and the forthcoming 2025 ESC/EACTS guidelines to offer practice-ready strategies tailored to the management of valvular...
Future devices for structural heart interventions
08 Feb 2025 – From PCR Tokyo Valves 2025
Get a glimpse into the future of structural heart interventions! This PCR Tokyo Valves 2025 session dives into the latest innovations in imaging and explores groundbreaking devices for mitral and tricuspid valve treatments. Watch as experts discuss how these advancements are set to reshape clinical practice.
Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE
20 May 2025 – From EuroPCR 2025
Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...
